Underpinning the Value of Urine for Predictive & Monitoring Biomarkers in Bladder Cancer
- Comparing utDNA with traditional ctDNA for monitoring disease burden and detecting recurrence
- Optimizing assay sensitivity, specificity & turnaround time for real-world clinical use
- Leveraging longitudinal utDNA analysis to guide treatment decisions and improve patient outcomes